VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration

Published:2021-02-03 Issue:2 Volume:62 Page:5
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Waters Stephen B.¹,Zhou Christopher¹,Nguyen Tara²,Zelkha Ruth²,Lee Hyun³,Kazlauskas Andrius²⁴,Rosenblatt Mark I.²,Malik Asrar B.¹,Yamada Kaori H.¹²

Affiliation:

1. Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, Illinois, United States

2. Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, Illinois, United States

3. Biophysics Core & Department of Pharmaceutical Sciences, University of Illinois College of Medicine, Chicago, Illinois, United States

4. Department of Physiology and Biophysics, University of Illinois College of Medicine, Chicago, Illinois, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CM082 suppresses hypoxia-induced retinal neovascularization in larval zebrafish;Frontiers in Pharmacology;2024-07-29

2. Characteristics of myopic maculopathy in Chinese children and adolescents with high myopia;British Journal of Ophthalmology;2024-07-26

3. Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications;Frontiers in Medicine;2024-07-19

4. Impact of defocus incorporated multiple segments (DIMS) spectacle lenses for myopia control on quality of life of the children: a qualitative study;BMJ Open Ophthalmology;2024-07

5. Drug-like properties of tyrosine kinase inhibitors in ophthalmology: Formulation and topical availability;International Journal of Pharmaceutics;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3